The Prognostic Effect of Dexamethasone on Patients With Glioblastoma: A Systematic Review and Meta-Analysis
Background: Dexamethasone (DEX) is widely adopted to reduce tumor-associated edema in glioblastoma (GBM) patients despite its side effects. However, the benefits of using DEX in GBM patients remains elusive.Methods: In this study, we performed a comprehensive meta-analysis to address this concern. W...
Main Authors: | Lingling Zhou, Yang Shen, Tingting Huang, Yangyang Sun, Raphael N. Alolga, Gang Zhang, Yuqiu Ge |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.727707/full |
Similar Items
-
Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies
by: Marta Cenciarini, et al.
Published: (2019-03-01) -
Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma
by: Paula Aldaz, et al.
Published: (2021-01-01) -
Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities
by: Patel Sunil J, et al.
Published: (2004-12-01) -
The role of adjunctive dexamethasone in the treatment of bacterial meningitis: an updated systematic meta-analysis
by: Shao M, et al.
Published: (2016-07-01) -
Efficacy of Dexamethasone for Acute Primary Immune Thrombocytopenia Compared to Prednisolone: A Systematic Review and Meta-analysis
by: Yasuyuki Arai, et al.
Published: (2017-07-01)